Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons-Reference-Cited by-同舟云学术

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

Published:2010-03-17 Issue:1 Volume:10 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Jackson Lisa A,Gaglani Manjusha J,Keyserling Harry L,Balser John,Bouveret Nancy,Fries Louis,Treanor John J

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-10-71/fulltext.html

Reference36 articles.

1. Schanzer DL, Langley JM, Tam TW: Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J. 2006, 25 (9): 795-800. 10.1097/01.inf.0000232632.86800.8c.

2. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K: Influenza-associated hospitalizations in the United States. JAMA. 2004, 292 (11): 1333-1340. 10.1001/jama.292.11.1333.

3. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003, 289 (2): 179-186. 10.1001/jama.289.2.179.

4. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB: The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007, 25 (27): 5086-5096. 10.1016/j.vaccine.2007.03.046.

5. Thompson WW, Comanor L, Shay DK: Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006, 194 (Suppl 2): S82-91. 10.1086/507558.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

2. Vaccines for Respiratory Viruses—COVID and Beyond;Vaccines;2024-08-22

3. WITHDRAWN: COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations;Life Sciences;2024-06

4. Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine;Pulmonology;2023-12

5. Identifying reasons for non-acceptance of influenza vaccine in healthcare workers: an observational study using declination form data;BMC Health Services Research;2023-10-27